At what serum ferritin level is iron infusion typically recommended for patients with iron deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Appropriate Iron Levels for Iron Infusion

Intravenous iron therapy is recommended when serum ferritin is <100 ng/mL or when ferritin is between 30-100 ng/mL with transferrin saturation <20%, especially in the presence of inflammation. 1

Diagnostic Criteria for Iron Deficiency

  • In patients without inflammation, a serum ferritin <30 ng/mL indicates absolute iron deficiency 1
  • In patients with inflammation or cancer, ferritin cutoff should be raised to <100 ng/mL to diagnose iron deficiency 1
  • When ferritin is between 30-100 ng/mL with transferrin saturation <20%, a combination of true iron deficiency and anemia of chronic disease is likely 1
  • Functional iron deficiency is characterized by low transferrin saturation (<20%) despite normal or elevated ferritin (up to 800 ng/mL) 1

Indications for Intravenous Iron Therapy

First-line IV Iron Therapy Recommended For:

  • Patients with clinically active inflammatory bowel disease 1
  • Patients with previous intolerance to oral iron 1
  • Patients with hemoglobin below 100 g/L 1
  • Patients requiring erythropoiesis-stimulating agents 1
  • Patients with cancer receiving chemotherapy who have functional iron deficiency 1, 2

Oral Iron Appropriate For:

  • Patients with mild anemia whose disease is clinically inactive 1
  • Patients without previous intolerance to oral iron 1

Special Considerations for Different Patient Populations

Cancer Patients:

  • IV iron is indicated for cancer patients with ferritin <100 ng/mL and transferrin saturation <20% 1
  • In functional iron deficiency (ferritin 30-800 ng/mL and TSAT <20%), IV iron can significantly improve hemoglobin levels 2
  • For cancer patients with ferritin >800 ng/mL or transferrin saturation ≥20%, IV iron supplementation is not needed 1

Chronic Kidney Disease:

  • Iron should be administered to maintain ferritin ≥100 ng/mL and transferrin saturation ≥20% in patients with hemoglobin <110 g/L 1
  • In patients requiring high doses of erythropoietic-stimulating agents, IV iron may be considered even with ferritin >800 ng/mL if transferrin saturation is <25% 1

Inflammatory Bowel Disease:

  • After successful treatment with IV iron, re-treatment should be initiated when ferritin drops below 100 mg/L 1

Monitoring and Safety

  • Monitor for hypersensitivity reactions during and after IV iron administration for at least 30 minutes 3
  • Check serum phosphate levels in patients requiring repeat courses of treatment, as hypophosphatemia can occur 3, 2
  • For patients with elevated ferritin levels, carefully assess the balance between benefits and risks of ongoing iron administration 1

Clinical Pitfalls to Avoid

  • Don't rely solely on ferritin without considering inflammation status - ferritin is an acute phase reactant that increases during inflammation 1, 4
  • Don't overlook functional iron deficiency in patients with chronic inflammatory conditions, even when ferritin appears normal 1, 4
  • Don't wait for severe anemia to develop before considering IV iron therapy in high-risk patients 1
  • Don't assume oral iron will be effective in patients with inflammatory conditions, as hepcidin activation can inhibit iron absorption 1, 2

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.